MetabolicCAGRILINTIDE
10MG
$120
Description
Cagrilintide is a long-acting amylin analog developed to work alongside GLP-1 receptor agonists for enhanced metabolic control. Amylin is a hormone co-secreted with insulin from pancreatic beta cells that plays a key role in regulating appetite, gastric emptying, and post-meal blood sugar spikes. Cagrilintide mimics and extends amylin's natural effects, slowing gastric emptying, promoting satiety, and reducing glucagon secretion. When paired with GLP-1 agonists like semaglutide, cagrilintide targets complementary appetite-regulating pathways in the brain, providing more comprehensive metabolic support than either compound alone.
Potential Benefits
Research Notes
Phase 2 and Phase 3 clinical trials by Novo Nordisk (the CagriSema program) have demonstrated that cagrilintide combined with semaglutide produces significantly greater weight reduction than either compound alone. The REDEFINE trials showed up to 22.7% body weight reduction with the combination. Cagrilintide's long-acting amylin analog mechanism represents a novel pathway distinct from GLP-1 agonism, making it a key compound in next-generation metabolic research.
BAC Water Notice
This peptide may be sensitive during mixing. The Pfizer 30ml BAC water works for all peptides. If using 10ml BAC water, you will need AA (Acetic Acid) Water — use a mixture of 25% AA Water and 75% Bacteriostatic Water. Please reach out before mixing if you need help.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.